beta-carotene and Candidiasis--Oral

beta-carotene has been researched along with Candidiasis--Oral* in 1 studies

Trials

1 trial(s) available for beta-carotene and Candidiasis--Oral

ArticleYear
Clinical and lymphocyte responses to beta-carotene supplementation in 11 HIV-positive patients with chronic oral candidiasis.
    Oral surgery, oral medicine, and oral pathology, 1994, Volume: 78, Issue:4

    Eleven HIV-positive patients with chronic oral candidiasis were supplemented with 60 to 120 mg of beta-carotene daily for 3 to 7 months. Lymphocyte profiles were evaluated at intervals to help assess immune competence. Although there was a modest increase in some lymphocyte values at 2 months, there was a significant decrease in numbers of CD4 and CD8 cells and CD4 percentage of lymphocytes after 6 months of beta-carotene supplementation. Serum triglyceride and liver enzyme levels were not affected by the beta-carotene supplementation. No improvement was observed in the control of the oral candidiasis. Under the conditions of the study, there was no indication that daily beta-carotene supplements enhanced immune competence or was of benefit in managing oral candidiasis.

    Topics: Adult; AIDS-Related Opportunistic Infections; Analysis of Variance; beta Carotene; Candidiasis, Oral; Carotenoids; CD4 Lymphocyte Count; Chronic Disease; Female; HIV Seropositivity; Humans; Lipids; Lymphocyte Count; Lymphocytes; Male; Middle Aged; Treatment Outcome

1994